Serial 88918431
Dead / Abandoned — Abandoned — no statement of use filed (as of 11 Mar 2024)
What this means for you
This application is over — abandoned 11 Mar 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88918431
- Mark type
- Design / logo
- Filed
- 15 May 2020
- Published for opposition
- 15 Dec 2020
- Abandoned
- 11 Mar 2024
- Attorney of record
- John Paul Oleksiuk
Goods and services
- Class 005 — Pharmaceuticals: Gene therapy products, namely biopharmaceutical preparations, primarily comprised of adeno-associated virus (AAV) vectors comprising a transgene for delivery to a cell or tissue, for the treatment of rare genetic diseases, conditions and disorders of muscle or the central nervous system; biological preparations as therapeutic products for medical use in medical and clinical gene therapy, namely, biological preparations for the treatment of rare genetic diseases, conditions and disorders of muscle or the central nervous system
Owner
- Affinia Therapeutics Inc., Waltham, MA, US
- Affinia Therapeutics Inc., Waltham, MA, US
Prosecution history
- 11 Mar 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 11 Mar 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 28 Jul 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Jul 2023 — SOU EXTENSION 5 GRANTED
- 19 Jul 2023 — SOU EXTENSION 5 FILED
- 27 Jul 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 19 Jul 2023 — SOU TEAS EXTENSION RECEIVED
- 07 Jan 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Jan 2023 — SOU EXTENSION 4 GRANTED
- 05 Jan 2023 — SOU EXTENSION 4 FILED
- 05 Jan 2023 — SOU TEAS EXTENSION RECEIVED
- 15 Jul 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Jul 2022 — SOU EXTENSION 3 GRANTED
- 13 Jul 2022 — SOU EXTENSION 3 FILED
- 13 Jul 2022 — SOU TEAS EXTENSION RECEIVED